Citigroup INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
Citigroup entities have updated their beneficial ownership filing for Wolfspeed, Inc., reporting a combined holding of 719,122 shares, representing 1.4% of the class.
NYSE
Citigroup Inc. and its subsidiaries have reported beneficial ownership of 14,636,273 ordinary shares, representing 6.0% of PureTech Health plc.
NYSE
Vanguard Capital Management has reported beneficial ownership of 126,457,408 shares of Citigroup Inc. common stock, representing 7.22% of the class.
NYSE
The Vanguard Group has filed an amended Schedule 13G for Citigroup Inc., reporting zero beneficial ownership following an internal realignment.
NYSE
Citigroup entities have reported a 6.4% beneficial ownership stake in Wolfspeed, Inc., totaling 2,879,188 common shares.
NYSE
Citigroup Inc. and its affiliates have reported beneficial ownership of 8.3% of Smartrent, Inc.'s Class A Common Stock.
NYSE
Citigroup and its affiliates have disclosed a 5.5% beneficial ownership stake in Puretech Health Plc, holding over 13.2 million ordinary shares.
NYSE
Citigroup Global Markets Inc. and its affiliates have disclosed a passive beneficial ownership of 4.3% of Nextcure, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing its beneficial ownership of 6.9% of Citigroup Inc.'s common stock as of March 31, 2025.
NYSE
Citigroup Global Markets Inc., Citigroup Financial Products Inc., Citigroup Global Markets Holdings Inc., and Citigroup Inc. have jointly disclosed a passive 6.1% beneficial ownership stake in Smartrent, Inc.'s Class A Common Stock as of December 31, 2024.
NYSE
Citigroup Global Markets Inc., Citigroup Financial Products Inc., Citigroup Global Markets Holdings Inc., and Citigroup Inc. have jointly reported a 3.7% passive beneficial ownership stake in Innoviz Technologies Ltd. as of December 31, 2024.
NYSE
Citigroup Global Markets Limited and affiliated entities have filed an amended Schedule 13G, reporting a collective beneficial ownership of 4.5% of Puretech Health Plc's Ordinary Shares as of December 31, 2024.